GlaxoSmithKline
GSK
C$52.14
Share price
0.03%
Change (1 day)
-1.17%
Change (1 year)
Categories
Market capitalization of GlaxoSmithKline (GSK)
Market cap: C$106.01 Billion
As of July 2025 GlaxoSmithKline has a market cap of C$106.01 Billion. This makes GlaxoSmithKline the world's 269th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of GlaxoSmithKline from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | C$106.01 B | 6.25% |
| 2024 | C$99.77 B | -1.34% |
| 2023 | C$101.13 B | 3.61% |
| 2022 | C$97.61 B | -29.8% |
| 2021 | C$139.04 B | 18.84% |
| 2020 | C$117.00 B | -23.03% |
| 2019 | C$152.00 B | 18.79% |
| 2018 | C$127.96 B | 15.5% |
| 2017 | C$110.78 B | -12.5% |
| 2016 | C$126.61 B | -7.85% |
| 2015 | C$137.41 B | 13.67% |
| 2014 | C$120.88 B | -11.98% |
| 2013 | C$137.33 B | 30.57% |
| 2012 | C$105.17 B | -10.24% |
| 2011 | C$117.17 B | 15.04% |
| 2010 | C$101.85 B | -11.72% |
| 2009 | C$115.38 B | -1.83% |
| 2008 | C$117.53 B | -15.11% |
| 2007 | C$138.45 B | -21.68% |
| 2006 | C$176.78 B | 3.04% |
| 2005 | C$171.57 B | 1.53% |
| 2004 | C$168.98 B | -1.08% |
| 2003 | C$170.82 B | -4.14% |
| 2002 | C$178.21 B | -27.25% |
| 2001 | C$244.96 B | -7.19% |
| 2000 | C$263.92 B | 79.91% |
| 1999 | C$146.70 B | -24.27% |
| 1998 | C$193.71 B | 58.44% |
| 1997 | C$122.26 B | 58.59% |
| 1996 | C$77.09 B |
End of Day market cap according to different sources
On Jul 7th, 2025 the market cap of GlaxoSmithKline was reported to be:
C$106.81 Billion
C$105.44 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 AstraZeneca AZN | C$298.96 B | 182.00% | 🇬🇧 UK |
 Pfizer PFE | C$195.91 B | 84.80% | 🇺🇸 USA |
 Merck MRK | C$277.34 B | 161.61% | 🇺🇸 USA |
 Novartis NVS | C$331.30 B | 212.50% | 🇨🇭 Switzerland |
 Sanofi SNY | C$162.96 B | 53.72% | 🇫🇷 France |
 Teva Pharmaceutical Industries TEVA | C$26.71 B | -74.80% | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | C$1.68 B | -98.41% | 🇺🇸 USA |